About Derma Sciences
Derma Sciences, Inc. (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. The Company's advanced wound care product line consists of MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products principally consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners and skin care products. The Company's traditional wound care product line includes branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Instruments & Supplies
- Sub-Industry: Health Care Supplies
- Exchange: NASDAQ
- Symbol: DSCI
- CUSIP: 24982750
- Previous Close: $7.00
- 50 Day Moving Average: $6.72
- 200 Day Moving Average: $5.25
- 52-Week Range: $2.92 - $7.05
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -63.64
- P/E Growth: 0.00
- Market Cap: $197.88M
- Outstanding Shares: 28,269,000
- Beta: 1.03
- Net Margins: -12.32%
- Return on Equity: -4.09%
- Return on Assets: -3.22%
Companies Related to Derma Sciences:
- Current Ratio: 1.29%
- Quick Ratio: 1.02%
What is Derma Sciences' stock symbol?
Derma Sciences trades on the NASDAQ under the ticker symbol "DSCI."
When will Derma Sciences announce their earnings?
Derma Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, March, 14th 2017.
Who owns Derma Sciences stock?
Derma Sciences' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Franklin Resources Inc. (9.44%), Broadfin Capital LLC (9.06%), Renaissance Technologies LLC (2.23%), Royce & Associates LP (1.94%) and Dimensional Fund Advisors LP (0.26%). Company insiders that own Derma Sciences stock include Brett Hewlett, Bruce F Wesson, Edward J Quilty, Robert C Cole, Samuel E Navarro and Srini Conjeevaram.
Who sold Derma Sciences stock? Who is selling Derma Sciences stock?
Derma Sciences' stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Renaissance Technologies LLC and Dimensional Fund Advisors LP.
Who bought Derma Sciences stock? Who is buying Derma Sciences stock?
Derma Sciences' stock was purchased by a variety of institutional investors in the last quarter, including Royce & Associates LP. Company insiders that have bought Derma Sciences stock in the last two years include Bruce F Wesson, Edward J Quilty, Robert C Cole, Samuel E Navarro and Srini Conjeevaram.
How do I buy Derma Sciences stock?
Shares of Derma Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Derma Sciences stock cost?
One share of Derma Sciences stock can currently be purchased for approximately $7.00.